Загрузка...
FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but not after Medical Management in Patients with Type 2 Diabetes
PURPOSE: To quantify changes in fibroblast growth factor 19 (FGF19) and bile acids (BAs) in patients with uncontrolled type 2 diabetes randomized to Roux-en-Y gastric bypass (RYGB) vs intensive medical management (IMM) and matched for similar reduction in HbA1c after 1 year of treatment. MATERIALS A...
Сохранить в:
| Опубликовано в: : | Obes Surg |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4751075/ https://ncbi.nlm.nih.gov/pubmed/26259981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11695-015-1834-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|